Use of protein kinase N beta

Details for Australian Patent Application No. 2003260399 (hide)

International Classifications

Event Publications

20 November 2003 Complete Application Filed

Priority application(s): 02018572.4 14.08.02 EP; 60/409,570 11.09.02 US

6 May 2004 Application Open to Public Inspection

Published as AU-B-2003260399

3 December 2009 Application Accepted

Published as AU-B-2003260399

4 February 2010 Amendment Made

The nature of the amendment is: Amend the applicant name from Atugen AG to Silence Therapeutics AG

1 April 2010 Application for Amendment

The nature of the amendment is: Amend the name of the inventor from Kaufmann, Jorg to Kaufmann, Joerg. Address for service in Australia - PIZZEYS Level 14, ANZ Centre 324 Queen Street Brisbane QLD 4000

8 July 2010 Amendment Made

The nature of the amendment is: Amend the name of the inventor from Kaufmann, Jorg to Kaufmann, Joerg

15 July 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.